Age-related macular degeneration.

Lancet
Laurence S LimTien Y Wong

Abstract

Age-related macular degeneration is a major cause of blindness worldwide. With ageing populations in many countries, more than 20% might have the disorder. Advanced age-related macular degeneration, including neovascular age-related macular degeneration (wet) and geographic atrophy (late dry), is associated with substantial, progressive visual impairment. Major risk factors include cigarette smoking, nutritional factors, cardiovascular diseases, and genetic markers, including genes regulating complement, lipid, angiogenic, and extracellular matrix pathways. Some studies have suggested a declining prevalence of age-related macular degeneration, perhaps due to reduced exposure to modifiable risk factors. Accurate diagnosis combines clinical examination and investigations, including retinal photography, angiography, and optical coherence tomography. Dietary anti-oxidant supplementation slows progression of the disease. Treatment for neovascular age-related macular degeneration incorporates intraocular injections of anti-VEGF agents, occasionally combined with other modalities. Evidence suggests that two commonly used anti-VEGF therapies, ranibizumab and bevacizumab, have similar efficacy, but possible differences in systemic safet...Continue Reading

References

Jul 1, 1991·Ophthalmology·R KleinL Hubbard
Jul 1, 1993·Ophthalmology·M A SandbergA R Gaudio
Mar 9, 2002·Retina·UNKNOWN Verteporfin Roundtable 2000 and 2001 ParticipantsUNKNOWN Verteporfin in photodynamic therapy (VIP) study group principal investigators
Oct 6, 2006·The New England Journal of Medicine·David M BrownUNKNOWN ANCHOR Study Group
Dec 13, 2006·Archives of Ophthalmology·David B ReinJinan Saaddine
Jan 24, 2007·American Journal of Ophthalmology·Frank G HolzUNKNOWN FAM-Study Group
May 1, 2007·Ophthalmology·Sophie J BakriRavinder J Singh
Jul 16, 2008·Progress in Retinal and Eye Research·Salvatore Grisanti, Olcay Tatar
Aug 8, 2008·European Journal of Human Genetics : EJHG·Jesen A FagernessJohanna M Seddon
Aug 22, 2009·Expert Opinion on Investigational Drugs·James A DixonNaresh Mandava
Oct 27, 2009·Progress in Retinal and Eye Research·Augustinus LaudeTin Aung
Jan 20, 2011·Investigative Ophthalmology & Visual Science·Sanjeewa S WickremasingheRobyn Guymer

❮ Previous
Next ❯

Citations

Jan 11, 2013·JAMA Ophthalmology·Jeremy A LavineNader Sheibani
Feb 21, 2013·Drugs & Aging·Sean W Tsao, Donald S Fong
May 21, 2013·Traffic Injury Prevention·Nicole GruberTobias Nef
Mar 5, 2013·Journal of Translational Medicine·Heather MelvilleNady Golestaneh
Jul 23, 2014·PloS One·Mamoru KamoshitaKazuo Tsubota
Dec 29, 2012·Sensors·Marco LombardoGiuseppe Lombardo
Dec 3, 2013·Progress in Retinal and Eye Research·Nicole T M SaksensCarel B Hoyng
Mar 20, 2013·Cellular and Molecular Life Sciences : CMLS·Lisa GherardiniTommaso Pizzorusso
Jan 15, 2014·Metallomics : Integrated Biometal Science·Héctor Gonzalez-IglesiasMiguel Coca-Prados
Apr 3, 2014·The Journal of Clinical Investigation·Frank G HolzMonika Fleckenstein
Jan 7, 2014·Oman Journal of Ophthalmology·Marcus Kernt, Anselm Kampik
Oct 31, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Elad MoisseievIrina S Barequet
Dec 19, 2012·Regenerative Medicine·Timothy A BlenkinsopJeffrey H Stern
Apr 9, 2014·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yujuan WangChi-Chao Chan
Apr 20, 2014·Ageing Research Reviews·F RocaE Boulanger
Mar 20, 2013·International Journal of Inflammation·Ishaq A ViringipurampeerKevin Gregory-Evans
Jan 1, 2014·Progress in Retinal and Eye Research·Lucia Sobrin, Johanna M Seddon
Feb 8, 2014·The British Journal of Nutrition·Bamini GopinathPaul Mitchell
Jun 19, 2014·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jun-Ru PanJun Hu
Dec 24, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Florian M HeussenBert Müller
Mar 26, 2014·Journal of Molecular Neuroscience : MN·Qinmeng ShuGezhi Xu
Oct 12, 2013·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·J AugeS Schmitz-Valckenberg
Feb 26, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Christina A KorbAlireza Mirshahi
Nov 13, 2013·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Leisa L Marshall, J Michael Roach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Genetics & Epigenetics of Aging

Dozens of genes are implicated in lifespan, and epigenetic changes during aging affect cell function. This feed focuses on the genetics and epigenetics of aging.